9 November 2025 - Australians living with chronic liver disease will soon have access to a new cheaper medicine on the PBS.
Elafibranor (Iqirvo) will be listed for the first time on the PBS for the treatment of primary biliary cholangitis, a chronic liver disease that damages the bile ducts and causes inflammation and scarring. It can lead to symptoms such as fatigue and itching and may progress to liver failure.